| 711388 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab |
2021-07-01 |
10.1136/jitc-2021-002742 |
Alexander James L, Ibraheim Hajir, Sheth Bhavisha, Little Jessica, Khan Muhammad Saheb, Richards Camellia, Hunter Nikki, Chauhan Dharmisha, Ratnakumaran Raguprakash, McHugh Kathleen, Pinato David J, Nathan Paul, Choy Julia, Crusz Shanthini M, Furness Andrew, Turajlic Samra, Pickering Lisa, Larkin James, Teare Julian P, Papa Sophie, Speight Ally, Sharma Anand, Powell Nick |
| 711387 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors |
2021-07-01 |
10.1136/jitc-2021-002459 |
Tan Aaron C, Bagley Stephen J, Wen Patrick Y, Lim Michael, Platten Michael, Colman Howard, Ashley David M, Wick Wolfgang, Chang Susan M, Galanis Evanthia, Mansouri Alireza, Khagi Simon, Mehta Minesh P, Heimberger Amy B, Puduvalli Vinay K, Reardon David A, Sahebjam Solmaz, Simes John, Antonia Scott J, Berry Don, Khasraw Mustafa |
| 711386 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy |
2021-07-01 |
10.1136/jitc-2020-002256 |
Lauret Marie Joseph Elodie, Kirilovsky Amos, Lecoester Benoît, El Sissy Carine, Boullerot Laura, Rangan Laurie, Marguier Amélie, Tochet Florent, Dosset Magalie, Boustani Jihane, Ravel Patrice, Boidot Romain, Spehner Laurie, Haicheur-Adjouri Nacilla, Marliot Florence, Pallandre Jean-René, Bonnefoy Francis, Scripcariu Viorel, Van den Eynde Marc, Cornillot Emmanuel, Mirjolet Céline, Pages Franck, Adotevi Olivier |
| 711385 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer |
2021-07-01 |
10.1136/jitc-2020-002261 |
Maslov Diana V, Tawagi Karine, KC Madhav, Simenson Victoria, Yuan Helen, Parent Cameron, Bamnolker Adi, Goel Richa, Blake Zoe, Matrana Marc R, Johnson Daniel H |
| 711384 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Expression of KLRG1 and CD127 defines distinct CD8+ subsets that differentially impact patient outcome in follicular lymphoma |
2021-07-01 |
10.1136/jitc-2021-002662 |
Wu Hongyan, Tang Xinyi, Kim Hyo Jin, Jalali Shahrzad, Pritchett Joshua C, Villasboas Jose C, Novak Anne J, Yang Zhi-Zhang, Ansell Stephen M |
| 711383 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead |
2021-07-01 |
10.1136/jitc-2021-002723 |
Kirtane Kedar, Elmariah Hany, Chung Christine H, Abate-Daga Daniel |
| 711382 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study |
2021-07-01 |
10.1136/jitc-2021-002447 |
Naing Aung, Thistlethwaite Fiona, De Vries Elisabeth G.E., Eskens Ferry A.L.M., Uboha Nataliya, Ott Patrick A., LoRusso Patricia, Garcia-Corbacho Javier, Boni Valentina, Bendell Johanna, Autio Karen A., Randhawa Manreet, Durm Greg, Gil-Martin Marta, Stroh Mark, Hannah Alison L., Arkenau Hendrik-Tobias, Spira Alexander |
| 711381 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study |
2021-07-01 |
10.1136/jitc-2021-002446 |
Sanborn Rachel E, Hamid Omid, de Vries Elisabeth GE, Ott Patrick A, Garcia-Corbacho Javier, Boni Valentina, Bendell Johanna, Autio Karen A, Cho Daniel C, Plummer Ruth, Stroh Mark, Lu Lawrence, Thistlethwaite Fiona |
| 711380 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing |
2021-07-01 |
10.1136/jitc-2021-002595 |
Lu Yong-Chen, Zheng Zhili, Lowery Frank J, Gartner Jared J, Prickett Todd D, Robbins Paul F, Rosenberg Steven A |
| 711379 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer |
2021-07-01 |
10.1136/jitc-2021-002528 |
Wu Si-Yu, Xiao Yi, Wei Jin-Li, Xu Xiao-En, Jin Xi, Hu Xin, Li Da-Qiang, Jiang Yi-Zhou, Shao Zhi-Ming |
